279 related articles for article (PubMed ID: 34436249)
41. Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer's disease, Parkinson's disease and ischemic brain stroke: their molecular targets and action mechanisms.
Choi DY; Choi H
Arch Pharm Res; 2015 Feb; 38(2):139-70. PubMed ID: 25348867
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and biological evaluation of new N-benzylpyridinium-based benzoheterocycles as potential anti-Alzheimer's agents.
Salehi N; Mirjalili BBF; Nadri H; Abdolahi Z; Forootanfar H; Samzadeh-Kermani A; Küçükkılınç TT; Ayazgok B; Emami S; Haririan I; Sharifzadeh M; Foroumadi A; Khoobi M
Bioorg Chem; 2019 Mar; 83():559-568. PubMed ID: 30471578
[TBL] [Abstract][Full Text] [Related]
43. Semi-synthesis and biological evaluation of flavone hybrids as multifunctional agents for the potential treatment of Alzheimer's disease.
Shi S; Wang H; Wang J; Wang Y; Xue X; Hou Z; Yao GD; Huang XX; Zhao H; Liu Q; Song SJ
Bioorg Chem; 2020 Jul; 100():103917. PubMed ID: 32442817
[TBL] [Abstract][Full Text] [Related]
44. Biphenylalkoxyamine Derivatives-Histamine H
Łażewska D; Zaręba P; Godyń J; Doroz-Płonka A; Frank A; Reiner-Link D; Bajda M; Stary D; Mogilski S; Olejarz-Maciej A; Kaleta M; Stark H; Malawska B; Kieć-Kononowicz K
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208297
[TBL] [Abstract][Full Text] [Related]
45. Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.
Jiang X; Zhang Z; Zuo J; Wu C; Zha L; Xu Y; Wang S; Shi J; Liu XH; Zhang J; Tang W
Eur J Med Chem; 2021 Nov; 223():113735. PubMed ID: 34371367
[TBL] [Abstract][Full Text] [Related]
46. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis and evaluation of novel indandione derivatives as multifunctional agents with cholinesterase inhibition, anti-β-amyloid aggregation, antioxidant and neuroprotection properties against Alzheimer's disease.
Mishra CB; Manral A; Kumari S; Saini V; Tiwari M
Bioorg Med Chem; 2016 Aug; 24(16):3829-41. PubMed ID: 27353888
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer's disease.
Choubey PK; Tripathi A; Tripathi MK; Seth A; Shrivastava SK
Bioorg Chem; 2021 Jun; 111():104922. PubMed ID: 33945941
[TBL] [Abstract][Full Text] [Related]
50. In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
Gurjar AS; Darekar MN; Yeong KY; Ooi L
Bioorg Med Chem; 2018 May; 26(8):1511-1522. PubMed ID: 29429576
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, Molecular Docking, and Preliminary Evaluation of 2-(1,2,3-Triazoyl)benzaldehydes As Multifunctional Agents for the Treatment of Alzheimer's Disease.
Costa GP; Baldinotti RSM; Fronza MG; Nascimento JER; Dias ÍFC; Sonego MS; Seixas FK; Collares T; Perin G; Jacob RG; Savegnago L; Alves D
ChemMedChem; 2020 Apr; 15(7):610-622. PubMed ID: 32012463
[TBL] [Abstract][Full Text] [Related]
52. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
Larik FA; Shah MS; Saeed A; Shah HS; Channar PA; Bolte M; Iqbal J
Int J Biol Macromol; 2018 Sep; 116():144-150. PubMed ID: 29729344
[TBL] [Abstract][Full Text] [Related]
53. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
[TBL] [Abstract][Full Text] [Related]
54. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
Han J; Du Z; Lim MH
Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
[TBL] [Abstract][Full Text] [Related]
55. In Silico Identification and Experimental Validation of Novel Anti-Alzheimer's Multitargeted Ligands from a Marine Source Featuring a "2-Aminoimidazole plus Aromatic Group" Scaffold.
Vitale RM; Rispoli V; Desiderio D; Sgammato R; Thellung S; Canale C; Vassalli M; Carbone M; Ciavatta ML; Mollo E; Felicità V; Arcone R; Gavagnin Capoggiani M; Masullo M; Florio T; Amodeo P
ACS Chem Neurosci; 2018 Jun; 9(6):1290-1303. PubMed ID: 29473731
[TBL] [Abstract][Full Text] [Related]
56. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
57. A Computational Study of Natural Compounds from Bacopa monnieri in the Treatment of Alzheimer's Disease.
Jamal QMS; Siddiqui MU; Alharbi AH; Albejaidi F; Akhtar S; Alzohairy MA; Kamal MA; Kesari KK
Curr Pharm Des; 2020; 26(7):790-800. PubMed ID: 31894743
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis and biological evaluation of new benzoxazolone/benzothiazolone derivatives as multi-target agents against Alzheimer's disease.
Erdogan M; Kilic B; Sagkan RI; Aksakal F; Ercetin T; Gulcan HO; Dogruer DS
Eur J Med Chem; 2021 Feb; 212():113124. PubMed ID: 33395623
[TBL] [Abstract][Full Text] [Related]
59. Exploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer's Disease.
Rampa A; Bartolini M; Pruccoli L; Naldi M; Iriepa I; Moraleda I; Belluti F; Gobbi S; Tarozzi A; Bisi A
Molecules; 2018 Jul; 23(8):. PubMed ID: 30061534
[TBL] [Abstract][Full Text] [Related]
60. Identification of aplysinopsin as a blood-brain barrier permeable scaffold for anti-cholinesterase and anti-BACE-1 activity.
Nuthakki VK; Yadav Bheemanaboina RR; Bharate SB
Bioorg Chem; 2021 Feb; 107():104568. PubMed ID: 33418314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
